Home » Topics » BioWorld Science

BioWorld Science
RSS

New ROMK blockers identified at Bristol-Myers Squibb

April 28, 2020

Pliant Therapeutics discovers integrin alphavbeta1 and/or alphavbeta6 antagonists

April 28, 2020

Adavosertib shows clinical activity in uterine serous carcinoma

April 28, 2020

Pilot study data for ZX-008 as adjunctive therapy in sunflower syndrome

April 28, 2020

Preclinical data support development of FX-301 for post-operative pain

April 28, 2020

FDA approves Ongentys as add-on treatment for patients with Parkinson's disease

April 28, 2020

Pivotal ADVANCE-1 study of AXS-05 meets primary endpoint

April 28, 2020

FDA grants IND approval for phase III study of GV-971 in Alzheimer's disease

April 28, 2020

NRF2 wakes sleeping tumor cells

April 28, 2020

Heart failure hormone has role in sepsis

April 28, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...